These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 7330818

  • 1. Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma.
    Orstavik KH.
    Thromb Haemost; 1981 Dec 23; 46(4):684-6. PubMed ID: 7330818
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The abnormal factor IX of hemophilia B+ variants.
    Bertina RM, Veltkamp JJ.
    Thromb Haemost; 1978 Oct 31; 40(2):335-49. PubMed ID: 734633
    [Abstract] [Full Text] [Related]

  • 4. Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor.
    Osterud B, Kasper CK, Lavine KK, Prodanos C, Rapaport SI.
    Thromb Haemost; 1981 Feb 23; 45(1):55-9. PubMed ID: 7245126
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies.
    Buchanan GR, Kevy SV.
    Pediatrics; 1978 Nov 23; 62(5):767-74. PubMed ID: 724319
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization and experimental use of a monospecific antiserum to factor IX.
    Pechet L, Tiarks CY, Chang CH, Sudhindra RR, Lipworth L.
    Thromb Haemost; 1979 Feb 15; 40(3):455-64. PubMed ID: 106483
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
    Wu PC, Hamaguchi N, Yu YS, Shen MC, Lin SW.
    Thromb Haemost; 2000 Oct 15; 84(4):626-34. PubMed ID: 11057861
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma.
    Nordfang O, Valentin S, Beck TC, Hedner U.
    Thromb Haemost; 1991 Oct 01; 66(4):464-7. PubMed ID: 1796397
    [Abstract] [Full Text] [Related]

  • 14. [Effect of monoclonal antibody against human tissue factor pathway inhibitor on plasma coagulation time].
    Yang Y, He X, Li J, He S.
    Hunan Yi Ke Da Xue Xue Bao; 1997 Oct 01; 22(4):297-300. PubMed ID: 9868079
    [Abstract] [Full Text] [Related]

  • 15. [Hemophilia BM (abnormal factor IX in coagulation disorder) (author's transl)].
    Girolami A, Cella G, Patrassi G.
    Haematologica; 1974 Mar 01; 59(1):91-108. PubMed ID: 4212668
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sensitive solid phase enzyme immunoassay for factor IX antigen and classification of hemophilia B.
    Takamatsu J, Kamiya T, Ogata K, Sugihara T, Koie K, Kato K.
    Haemostasis; 1983 Mar 01; 13(1):9-16. PubMed ID: 6341181
    [Abstract] [Full Text] [Related]

  • 18. Studies on the prolonged prothrombin time in haemophilia BM.
    Elödi S.
    Thromb Diath Haemorrh; 1973 May 10; 29(2):247-52. PubMed ID: 4796945
    [No Abstract] [Full Text] [Related]

  • 19. [Factor IX and factor IX inhibitor].
    Higasa S.
    Nihon Rinsho; 2004 Dec 10; 62 Suppl 12():647-50. PubMed ID: 15658413
    [No Abstract] [Full Text] [Related]

  • 20. Laboratory identification of factor inhibitors: the perspective of a large tertiary hemophilia center.
    Kershaw G, Jayakodi D, Dunkley S.
    Semin Thromb Hemost; 2009 Nov 10; 35(8):760-8. PubMed ID: 20169512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.